Einstein Probe caught a stellar X-ray flare on November 6; SVOM confirmed it in 312 seconds with three-color photometry, ...
Cooperative board game Take Time has won three international awards and launches its first expansion -- Take Time: Mirage -- at US retail on October 2, 2026 for $9.99. This buyer guide explains the ...
FDA formally investigates Zolgensma cancer risk after confirming GLI1 oncogene activation; Itvisma also added to cancer probe ...
Bayer’s asundexian reduces recurrent stroke risk 26% without added bleeding in OCEANIC-STROKE. Approved in China (Sunharbo®); ...
The HiBy RS2 II brings Darwin III FPGA-driven R2R architecture from the $3,899 RS8 II flagship into a $439 DAP — the only sub ...
Four-year brightening of changing-look black hole AT2022aamy confirmed. Its unusual spectrum may be first real-time test of ...
Zylox-Tonbridge and GL Capital have conditionally agreed to subscribe for 16.7% of LifeTech Scientific for $189M, with ...
ARO-DIMER-PA, Arrowhead Pharmaceuticals’ investigational dual-gene RNAi drug, posted 54% LDL cholesterol and 73% triglyceride ...
Wing plans a $125 million Fort Worth drone factory capable of producing tens of thousands of aircraft annually as it scales U ...
Thirty million Delhi-NCR residents are entering the most dangerous air quality window of the year this weekend, with ...
Galactic Energy Ceres-2 launch marks China’s first confirmed orbital success after a nozzle failure destroyed its January ...
FDA has confirmed Zolgensma activated a cancer gene in treated children; nine tumor reports now shift gene therapy’s theoretical risk to confirmed reality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results